GlobeNewswire by notified

Active Biotech Delårsrapport januari – september 2019  

Dela

    

Väsentliga händelser under kvartal 3

  • Framtagande av en ny affärsplan för laquinimod och tasquinimod, baserad på de omfattande tidigare framtagna prekliniska och kliniska data, pågår
  • Data från fas 2-studien LEGATO-HD med laquinimod i Huntingtons sjukdom presenterades på den internationella kongressen Parkinson’s disease and movement disorders


Händelser efter periodens utgång

  • Första patienten har doserats i fas 1b-studien av naptumomab estafenatox i kombination med durvalumab i solida tumörer
  • Prekliniska data för naptumomab estafenatox presenterades vid Society for Immunotherapy of Cancer’s 34th Annual Meeting

Ekonomisk översikt  

MSEK Q3 Q1-Q3 Helår
  2019 2018 2019 2018 2018
           
Nettoomsättning 0,9 4,7 7,5 15,2 20,1
Rörelseresultat -9,3 -6,9 -21,1 -22,8 -29,8
Resultat efter skatt -9,3 -8,7 -22,9 -28,0 -36,9
Resultat per aktie (SEK) -0,06 -0,06 -0,16 -0,21 -0,27
Likvida medel (vid periodens slut)     69,9 36,0 25,6

För ytterligare information, vänligen kontakta:

  Helén Tuvesson, VD
  Tfn 046-19 21 56

 

  Hans Kolam, CFO
  Tfn 046-19 20 44
Active Biotech AB
(org.nr 556223-9227)
Box 724, 220 07 Lund
Tfn 046-19 20 00
 

Rapporten finns även tillgänglig på www.activebiotech.com .


Active Biotech är skyldigt att offentliggöra informationen i denna delårsrapport enligt EU:s marknadsmissbruksförordning. Informationen lämnades, genom ovanstående kontaktpersons försorg, för offentliggörande den 14 november, 2019, kl. 08.30. 

Bilaga

För att se det här innehållet från www.globenewswire.com måste du ge ditt medgivande sidans topp.

Om

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Följ GlobeNewswire by notified

Abonnera på våra pressmeddelanden. Endast mejladress behövs och den används bara här. Du kan avanmäla dig när som helst.

Senaste pressmeddelandena från GlobeNewswire by notified

Q1-2024: 50% Revenue Growth, March Shows Positive Net Result for Continuing Business16.4.2024 09:10:00 CEST | Press release

Company Announcement no. 149 – 2024 Copenhagen, April 16th, 2024 Q1-2024: 50% Revenue Growth, March Shows Positive Net Result for Continuing Business GreenMobility's continuing operations generated a revenue growth of 50% in Q1-2024 compared to Q1-2023, and a positive net result for the month of March. In Q1 2024, which is seasonally the weakest quarter for GreenMobility, the continuing operations have been significantly improving month by month. The number of trips in Copenhagen grew to more than 60,000 in January, then in February the number of trips surpassed 70,000, and in March a total of more than 80,000 trips. This trend highlights the growth potential and that the market can absorb the number of cars being moved to Denmark from the international markets. On the financial side the net result from continuing operations also significantly improved month by month, and March ended with a positive net result, highlighting that GreenMobility is on track to reach the goal of profitabil

Investeringsforeningen IA Invest, Afdeling Thygesen Global Stock Selection – Prospekt, dokument med central information og tegningsblanket16.4.2024 09:02:23 CEST | pressemeddelelse

Investeringsforeningen IA Invest har indledende tegningsperiode i følgende afdeling fra den 22. april til og med den 3. maj 2024: AfdelingISIN-kodeTegningskurs (franco) Thygesen Global Stock Selection DK0062842134 100,20 Betalingsdag er den 8. maj 2024, og første handelsdag er den 14. maj 2024. Prospekt, dokument med central information samt tegningsblanket er vedhæftet denne meddelelse. For yderligere information henvises der til henholdsvis foreningens og afdelingens hjemmeside www.iainvest.dk og www.thygesencapital.dk. Eventuelle henvendelser vedrørende denne meddelelse bedes rettet til undertegnede på telefon 38 14 66 00. Med venlig hilsen Niels Erik Eberhard Direktør Vedhæftede filer IAI Prospekt_16-04-2024_clean inkl. SFDRIAI PRIIP KID Thygesen - DK0062842134 IAI Tegningsblanket Thygesen_clean

Invitation to presentation of Scatec ASA’s first quarter results 202416.4.2024 09:00:00 CEST | Press release

Oslo, 16 April 2024: Scatec ASA will release its first quarter results on Tuesday 30 April 2024 at 07:00 am (CEST). A presentation of the results followed by a Q&A session will be held on the same day at 09:00 am at Scatec’s headquarters at Skøyen Atrium III (1st floor), Askekroken11, 0277 Oslo. The presentation and the Q&A session can be followed through a live webcast from our website www.scatec.com, or Scatec webcast Q1 2024. For further information, please contact: For analysts and investors: Andreas Austrell, VP IR, andreas.austrell@scatec.com For media: Meera Bhatia, SVP Communications & Government Affairs, meera.bhatia@scatec.com About Scatec Scatec is a leading renewable energy solutions provider, accelerating access to reliable and affordable clean energy emerging markets. As a long-term player, we develop, build, own, and operate renewable energy plants, with 4.6 GW in operation and under construction across four continents today. We are committed to grow our renewable energy

DNA Plc: Change in the Executive Team16.4.2024 09:00:00 CEST | Press release

DNA PLC STOCK EXCHANGE RELEASE 16 APRIL 2024 10:00 am (EEST) DNA Plc’s Chief Technical Officer (CTO) and member of the Executive Team, Ville Virtanen (eMBA, B. Eng.), will leave his position and his seat in DNA's Executive Team on 30 April 2024 to join DNA’s parent company Telenor, the Norwegian telecommunications group. In his new role, he will serve as SVP Nordic Technology Transformation of Telenor Nordics, which is Telenor's umbrella organization in Nordics region. The search for a new CTO for DNA will start immediately. Mr. Virtanen has more than 20 years of experience at DNA. Before taking the role of CTO in autumn 2021, he was heading the Core and IP Networks unit. "Over the past years, Ville's extensive knowledge of various network technologies has been the key to DNA's development of its technical capabilities, for example transition to the era of high-speed 5G in its mobile networks. At the heart of Ville's actions has always been the question of which technical solutions ena

Investeringsforeningen IA Invest, Afdeling Furesø Globale Kvalitetsaktier – Prospekt, dokument med central information og tegningsblanket16.4.2024 08:58:53 CEST | pressemeddelelse

Investeringsforeningen IA Invest har indledende tegningsperiode i følgende afdeling fra den 22. april til og med den 3. maj 2024: AfdelingISIN-kodeTegningskurs (franco)Furesø Globale KvalitetsaktierDK0062842217 100,20 Betalingsdag er den 8. maj 2024, og første handelsdag er den 14. maj 2024. Prospekt, dokument med central information samt tegningsblanket er vedhæftet denne meddelelse. For yderligere information henvises der til henholdsvis foreningens og afdelingens hjemmeside www.iainvest.dk og www.furesoekapital.dk. Eventuelle henvendelser vedrørende denne meddelelse bedes rettet til undertegnede på telefon 38 14 66 00. Med venlig hilsen Niels Erik Eberhard Direktør Vedhæftede filer IAI Prospekt_16-04-2024_clean inkl. SFDR IAI PRIIP KID Furesø 2024.04.16 DK0062842217IAI Tegningsblanket Furesø_clean

HiddenA line styled icon from Orion Icon Library.Eye